About us
Ninotalem' − High quality melatonin tablets
Melatonin, a natural hormone, plays a vital role in regulating the
circadian rhythm (or 'biological clock') of the human body. Disturbances
of the body's melatonin levels are implicated in a variety disorders,
ranging from sleep disturbances and jet-lag to seasonal affective
disorder (a type of depression). In addition, melatonin is a potent
antioxidant, can positively affect immunodepression and has shown
positive results as an adjuvant to certain types of cancer therapy.
Circa Dia has developed Ninotalem' tablets that contain synthetic
melatonin of high quality and consistency. Circa Dia's Ninotalem' has
been extensively tested in formal toxicology studies and in several
clinical studies involving more than 1,000 subjects. All with clear and
positive results. Based on these results, Circa Dia has been granted a
product license for Ninotalem' by Health Canada for use in sleep
disorders.
Circa Dia is now looking for partners to develop additional
melatonin-based drugs for both adults and children and to develop the
Canadian market (and others) for Ninotalem'. Circa Dia is also open for
discussions on product licenses for Ninotalem'.
Company profile
Circa Dia B.V. is a privately held company founded in 1998 and
located in Amsterdam and The Hague, The Netherlands. The company builds
on longstanding melatonin research by renowned melatonin expert Wop J.
Rietveld, MD, PhD, chairman of the International Society for
Chronobiology and Scientific Director of Circa Dia.
|